Anti-phospho-EGFR (Tyr845) Antibody

32160702

NA.41

Recognizes phospho-EGFR (Tyr845).
Predicted to cross-react with mouse and rat based on sequence homology (100%), but have not been tested.

Peptide corresponding to amino acid region encompassing the human, mouse, and rat phospho-EGFR (Tyr845)

Research Sub Category
Growth Factors & Receptors
Research Category
Signaling
This Anti-phospho-EGFR (Tyr845) Antibody is validated for use in IC, IF, IH, WB for the detection of phospho-EGFR (Tyr845).
Immunoblot Analysis: A 1:1000 dilution of this lot detected phospho-EGFR (Tyr845) in RIPA lysates from EGF stimulated A431 cells.

Routinely evaluated by immunoblot.

ImmunoAffinity Purified
Affinity Purified rabbit polyclonal IgG in 50% storage buffer (PBS (without Mg²⁺ and Ca²⁺), pH 7.3 containing 1.0 mg/mL BSA (IgG, protease free) and 0.05% sodium azide) and 50% glycerol.

Control
EGF stimulated A431 cells

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

rabbit

100

affinity purified immunoglobulin

primary antibodies

polyclonal

affinity chromatography

human

Upstate^®

immunocytochemistry: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable

NM_005228.3
NM_201282.1
NM_201283.1
NM_201284.1

P00533

dry ice

185 kDa

Maintain for 2 years at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

12 - Non Combustible Liquids

WGK 2